Na Su
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
-
- Pharmacology and Obesity Treatment
Papers in
-
- Diabetes Treatment and Management 9
- Diabetes Management and Research 3
- Surgery 10
- Lipoproteins and Cardiovascular Health 4
- Co-authors
- Sheyu Li (10 shared papers)Shengzhao Zhang (7 shared papers)Hanrui Zheng (5 shared papers)Qingyang Shi (2 shared papers)Yi Li (1 shared paper)Yuzhen Tong (1 shared paper)Haoming Tian (6 shared papers)Lizhi Tang (1 shared paper)
- Journals
- Frontiers in Pharmacology (5 papers)Frontiers in Endocrinology (3 papers)Frontiers in Oncology (2 papers)Heart (2 papers)International Journal of Cardiology (1 paper)
- Partner nations
- ChinaUnited StatesNorway
In The Last Decade
Na Su
42 papers receiving 500 citations
Peers
Comparison fields: 5 of 104
- Endocrinology, Diabetes and Metabolism 135
- Pharmacology 71
- Nephrology 29
- Cancer Research 48
- Surgery 120
Countries citing papers authored by Na Su
This map shows the geographic impact of Na Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Na Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Na Su more than expected).
Fields of papers citing papers by Na Su
This network shows the impact of papers produced by Na Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Na Su. The network helps show where Na Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Na Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 50 | |
| 2 | 2021 | 39 | |
| 3 | 2019 | 37 | |
| 4 | 2020 | 37 | |
| 5 | 2020 | 35 | |
| 6 | 2019 | 26 | |
| 7 | 2017 | 23 | |
| 8 | 2018 | 22 | |
| 9 | 2022 | 22 | |
| 10 | 2016 | 18 | |
| 11 | 2023 | 17 | |
| 12 | 2021 | 16 | |
| 13 | 2022 | 14 | |
| 14 | 2023 | 13 | |
| 15 | 2023 | 13 | |
| 16 | 1989 | 11 | |
| 17 | 2019 | 10 | |
| 18 | 2021 | 10 | |
| 19 | 2020 | 9 | |
| 20 | 2021 | 9 |
About Na Su
Na Su is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Molecular Biology, Immunology and Pulmonary and Respiratory Medicine, having authored 46 papers that have together received 505 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (9 papers), Lipoproteins and Cardiovascular Health (4 papers), Diabetes Management and Research (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers), Gout, Hyperuricemia, Uric Acid (3 papers), Metabolism, Diabetes, and Cancer (3 papers) and Pharmacology and Obesity Treatment (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (135 citations), Pharmacology (71 citations), Nephrology (29 citations), Cancer Research (48 citations) and Surgery (120 citations). Na Su has collaborated with scholars based in China, United States and Norway. Frequent co-authors include Sheyu Li, Shengzhao Zhang, Hanrui Zheng, Qingyang Shi, Yi Li, Yuzhen Tong, Haoming Tian, Lizhi Tang, Fang Zhang and Li Huang. Their work appears in journals such as Frontiers in Pharmacology, Frontiers in Endocrinology, Frontiers in Oncology, Heart and International Journal of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.